Sensenig Bethany 4
4 · KalVista Pharmaceuticals, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Sensenig Bethany
Director
Transactions
- Award
Stock Option (right to buy)
2025-10-01+45,000→ 45,000 totalExercise: $12.05Exp: 2035-09-30→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The option vests over a 3-year period: 1/36th vests on November 1, 2025, after which 1/36th of the total shares vest monthly, subject to reporting person's continued service through each vesting date.